CSI Market
Sign In | Register

Telix Pharmaceuticals Ltd (TLX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access TLX Annual Balance Sheets →
Balance sheet data covering Telix Pharmaceuticals Ltd–0 offers a view into how Jun 30 2026's financial position has changed alongside business activity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/TLX/balance-sheets
https://api.csimarket.com/api/v1/companies/TLX/fundamentals
https://api.csimarket.com/api/v1/companies/TLX/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Balance Sheet API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Dec 31 2025) 0 0 0
Assets
Cash And Cash Equivalents251.91
Current Tax Assets Current0.00
Cash & Short-term Investments251.00
Trade & Other Current Receivables (IFRS combined total)163.56
Notes Receivable, Current6.83
Inventories39.03
Other Current Assets190.25
Total Current Assets488.02
Equipment/Property/Plant Net72.24
Goodwill net0.00
Intangible Assets0.00
Deferred Tax Assets85.30
Intangible AssetsAnd Goodwill716.30
Total Assets1,361.85
Liabilities
Accounts Payable168.97
Short-term Debt504.88
Current Provisions0.52
Total Current Liabilities242.34
Long-term debt0.00
Total Long-term Debt0.00
Deferred Tax Liabilities, Net LI43.30
Noncurrent Provisions156.51
Total Liabilities874.18
Stockholders' Equity
Other Equity0.00
Common Stockholder's Equity487.68
Total Stockholder's Equity487.68
Liabilities & Stockholder's Equity1,361.85
4 historic quarters locked

Sign in to unlock the full Telix Pharmaceuticals Ltd balance sheet history.

Sign In Create Free Account

About Telix Pharmaceuticals Ltd Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 20-F (Period: 20251231)
  • Filed with the SEC: February 19, 2026
  • Source: tlx-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-26-009943

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI